Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on June 12, 2014, regarding events occurring on June 11, 2014. Acadia Healthcare Company, Inc. (Acadia) entered into a material definitive agreement to conduct a public offering of its common stock.
Key Financial Metrics and Transaction Details
- Offering Size: 7,727,273 shares of Common Stock (Firm Shares).
- Offering Price: $44.00 per share.
- Net Proceeds to Company: Approximately $325 million (after underwriting discounts and commissions, excluding the option).
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 1,159,090 additional shares.
- Use of Proceeds: Principally to fund the acquisition strategy, specifically the planned acquisition of Partnerships in Care, and related transaction fees and expenses.
- Selling Stockholder: A portion of the shares is being sold by a Selling Stockholder; Acadia receives no proceeds from these specific shares.
Material Changes and Agreements
The primary material change is the execution of an Underwriting Agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated and Jefferies LLC. The closing of the sale of Firm Shares is scheduled for or about June 17, 2014. Directors and executive officers of the Company and the Selling Stockholder have entered into 60-day lock-up agreements.
Outlook, Risks, and Contingencies
Management intends to utilize the capital raised to accelerate its acquisition strategy. The filing notes that affiliates of certain underwriters are lenders under the Company's senior secured credit facility. The transaction is subject to customary representations, warranties, covenants, and closing conditions. The filing does not provide specific revenue, profit, or cash flow metrics for the reporting period as this is a transactional filing rather than a periodic financial report.
Investor Verification Checklist
- Verify the final closing date of the offering (scheduled for June 17, 2014).
- Confirm whether the underwriters exercise the 30-day option to purchase additional shares.
- Review the definitive agreement for the acquisition of Partnerships in Care to confirm funding requirements.
- Check for any updates regarding the Selling Stockholder's portion of the sale.